Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...
Research links COVID vaccination to higher acute kidney injury risk within one year, though vaccinated people showed lower ...
Two major studies published this month are raising new questions about potential health risks associated with the COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback